Skip to main content

Amgen plans mega bond deal to help fund $28 billion Horizon Therapeutics acquisition

Amgen Inc. plans to finance its acquisition of Horizon Therapeutics in the corporate bond market, underscoring how the Federal Reserve's inflation fight isn't drying up mega deals on Wall Street.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.